Not how i see it, but hey, differing opinions are good. The money in this company is in MANF. That is the ONLY IP I think a BP would want. And CDNF is starting human trials THIS YEAR. MANF needs to move forward soon with BP who can back the trials. If any are snooping around AMBS, it is for ownership interest in MANF. As to non-core assets, I agree with you, I wouldn't be surprised to see some sort of deal there. But AMBS's core is MANF and that should be the focus - getting it into human trials.